Analysts Remain Bullish On Intuitive Surgical Despite Macro Uncertainty
1. ISRG Q1 2025 revenue reached $2.25 billion, exceeding estimates. 2. Installed base for da Vinci systems grew to 10,189, up 15%. 3. Analysts expect 15%-17% growth in global da Vinci procedures for 2025. 4. Truist lowers price target from $605 to $590, yet retains Buy rating. 5. Company's solid cash position enhances flexibility for future investments.